| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_846e66e8b612cd7b513a9483826b4f15 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2010-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f154b7519c2c9f48711c4f610f3b42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_919c10d0c485372bb53da4d8afa5096a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b665cc6bc35b0cbb5706567efe67241b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f5931fdabe2e4ff24d0dabd3fbb4cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef04e2bac3d10cd00ea62536f42ddad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9def1211c92d007243df079194a5dda6 |
| publicationDate |
2012-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120016055-A |
| titleOfInvention |
Antisulfate and Antioxidant Proteoglycan Antibodies and Uses thereof |
| abstract |
The present invention relates to biotechnology and in particular to new products for use in human health. The present invention provides novel characteristic monoclonal antibodies which have a high affinity with sulfatides and sulfated proteoglycans. The antisulfatides and anti-sulfated proteoglycan antibodies disclosed and described in the present description provide important diagnostic and therapeutic tools that act on the pathogenesis associated with the expression of atherosclerosis plaques. Accordingly, the present invention provides a pharmaceutical composition comprising the MAbs of the present invention or fractions thereof for therapeutic and diagnostic uses associated with cardiovascular disease. In particular, the present invention relates to fractions derived from MAbs that recognize sulfatides and sulfated proteoglycans that can be used in the treatment or diagnosis of this etiology. |
| priorityDate |
2009-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |